| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| gsk 3 beta inhibitor | 1.58 | 0.8 | 6564 | 57 | 20 |
| gsk | 1.73 | 1 | 8475 | 33 | 3 |
| 3 | 0.75 | 0.6 | 8094 | 68 | 1 |
| beta | 0.14 | 0.3 | 4600 | 51 | 4 |
| inhibitor | 0.49 | 0.1 | 2392 | 29 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| gsk 3 beta inhibitor | 1.94 | 0.4 | 6204 | 27 |
| gsk 3beta inhibitors | 1.16 | 0.7 | 6273 | 30 |
| gsk-3 inhibitor 3 | 1.71 | 0.7 | 9116 | 99 |
| gsk-3 inhibitor | 1.3 | 0.5 | 666 | 35 |
| gsk-3 inhibitor bio | 1.47 | 0.6 | 4050 | 62 |
| gsk 3b inhibitor clinical trial | 0.84 | 1 | 1833 | 7 |
| gsk 3 inhibitor ix | 0.12 | 0.9 | 1584 | 37 |
| gsk-3 beta | 0.8 | 0.2 | 991 | 47 |
| gsk3 inhibitor clinical trial | 1.47 | 0.3 | 4021 | 23 |
| gsk-3-inhibitor-ii | 1.68 | 0.7 | 8350 | 75 |
| gsk3-beta | 0.94 | 0.3 | 7734 | 5 |
| how to inhibit gsk3b | 0.73 | 0.1 | 9556 | 42 |
| anti-gsk3 beta role in inflammation | 1.13 | 0.5 | 455 | 40 |
| gsk 3 beta pathway | 0.04 | 0.1 | 8453 | 29 |
| anti-gsk3 beta role in cancer | 1.22 | 0.6 | 3664 | 38 |
| anti-gsk3 beta therapeutic potential | 0.48 | 0.5 | 9605 | 79 |
| anti-gsk3 beta role in diabetes | 1.01 | 0.5 | 3053 | 32 |
| anti-gsk3 beta role in bipolar disorder | 0.23 | 0.1 | 6839 | 54 |
| anti-gsk3 beta regulation by lithium | 1.5 | 0.1 | 1301 | 9 |
| anti-gsk3 beta role in neurogenesis | 1.88 | 0.7 | 4370 | 50 |
| gsk3-in-3 | 1.66 | 0.9 | 3102 | 20 |
| gsk3-like kinase | 1.38 | 0.8 | 3461 | 88 |
| what does gsk3 do | 0.09 | 0.6 | 6375 | 39 |
